A new study has analyzed proposed policies that would affect out-of-pocket prescription costs for Medicare Part D beneficiaries requiring specialty drugs who did not qualify for low-income subsidies. The study recommended implementing annual and monthly out-of-pocket spending limits that would create lower, more consistent costs, potentially increasing patients’ ability to access treatments for life-threatening, chronic, and rare diseases. Read the study here.
Last Updated on May 12, 2020 by Aimed Alliance
